Clinical Trial Update: Effect of B-cell Depleting Therapies on PLA2R-specific B Cells in Patients With Membranous Nephropathy [NA]

View source ↗

Summary

A completed clinical trial update examining how B-cell depleting therapies affect PLA2R-specific B cells in patients with membranous nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• B-cell depleting therapies

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Membranous Nephropathy | NA | Status: COMPLETED